2 ASX 200 shares to buy and hold for the next decade

These stocks have a very promising future.

Key points
  • Both of these companies have significant growth potential, driven by strategic goals, market dynamics, and innovation, appealing to investors seeking long-term value.
  • Sonic Healthcare achieved strong FY25 results with revenue growth of 8% and expects a 13% increase in EBITDA in FY26, fuelled by its global presence and adoption of AI.
  • Temple & Webster demonstrated a robust 21% revenue increase and operating profit growth of 43% in FY25, driven by its capital-light, online retail model.

S&P/ASX 200 Index (ASX: XJO) shares are typically strong businesses in their sectors and have the ability to achieve strong profit margins. I like companies that are delivering pleasing growth already and have good long-term outlooks.

Names like Commonwealth Bank of Australia (ASX: CBA) and Woolworths Group Ltd (ASX: WOW) already have a huge presence in the banking and supermarket sectors (respectively), and I can't see them growing their market share or margins significantly from here due to competition.

However, the two businesses below have lots of room to grow, in my opinion.   

long term and short term on white cubes

Image source: Getty Images

Sonic Healthcare Ltd (ASX: SHL)

This company is a large, international pathology business. It's also involved in radiology, general practice medicine, and corporate medical services.

Across its business, its diagnostic and clinical services are provided by 1,800 pathologists and radiologists, as well as over 17,000 medical scientists, radiographers, sonographers, technicians, and nurses. The board and management are also highly experienced medical personnel.

The business has a presence in a number of countries, including Australia, New Zealand, the US, the UK, Switzerland, and Germany.

It delivered solid results in FY25, with revenue growth of 8% to $9.6 billion, 8% operating profit (EBITDA) growth to $1.72 billion, net profit growth of 7% to $514 million, and operating cash flow growth of 21% to $1.3 billion.

The ASX 200 share expects to grow its EBITDA by around 13% in FY26. I think it could be an appealing investment at its current valuation, given its earnings growth potential. Earnings supports include ageing populations and growing populations in its key markets, increased usage of AI throughout its business, additional acquisitions, and new types of pathology methods.

In a decade, I believe the business could be larger and more profitable for shareholders.

Temple & Webster Group Ltd (ASX: TPW)

Temple & Webster is one of my favourite businesses in the retail space. It sells hundreds of thousands of products on its website, though a majority of those items are shipped directly by suppliers. This allows the business to sell a wider range of items and operate with a capital-light model.

Its operating model enables the business to generate a pleasing cash flow and invest heavily in further growth.

The FY25 result displayed a number of strong positives, with a 16% rise in active customers, 21% revenue growth to $601 million, and 43% growth of operating profit (EBITDA) to $18.8 million.

Operating leverage and AI are helping the business achieve stronger margins. Fixed costs as a percentage of revenue improved to 10.6% in FY25, down from 11.3% in FY24.

The ASX 200 share is tracking to plan across all of its long-term strategic goals, including its medium-term goal of at least $1 billion in annual revenue.

Temple & Webster said the Australian furniture and homewares market has 20% online penetration, compared to 35% in the US market and 29% in the UK market. That suggests further potential market share gains in the coming years.

Further upside for the business could be achieved through trade and commercial sales, international expansion, and new ventures.

It achieved an EBITDA margin of 3.1% in FY25, with expectations of between 3% to 5% in FY26. In the longer term, it's aiming for an EBITDA margin of at least 15%. Combined with rapidly rising revenue, I believe the ASX 200 share could become an even stronger presence in the coming years.

Motley Fool contributor Tristan Harrison has positions in Temple & Webster Group. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Temple & Webster Group. The Motley Fool Australia has recommended Sonic Healthcare and Temple & Webster Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

Piles of increasing coins alongside an hourglass.
Growth Shares

Why I just invested $1,500 into this top ASX growth share

I’m bullish on the future of this ASX growth share…

Read more »

Woman looking at data on her laptop.
Growth Shares

3 ASX 200 shares I would buy and hold for 10 years

These three businesses have the sort of growth runways I want for a 10-year investment.

Read more »

Coins in ascending order from left to right, with a piggy bank and clock on the sides.
Growth Shares

2 top ASX shares to buy and hold for the next decade

These two investments have incredible long-term outlooks.

Read more »

Rocket going up above mountains, symbolising a record high.
Growth Shares

2 ASX shares tipped to grow 100% or more in the next 12 months

These two stocks could deliver massive returns.

Read more »

Smiling woman pointing at rising graph.
Growth Shares

2 strong Australian stocks to buy now with $9,000

These stocks look like top buys to me right now.

Read more »

Wooden house and golden coins on balancing scale.
Growth Shares

Is the REA Group share price a strong contrarian buy?

Is this a good time to invest in the property portal business?

Read more »

Ascending piles of coins and plants in three jars, with a hand putting a coin in the first jar.
Growth Shares

A rare buying opportunity in 1 of Australia's top shares?

This stock is an ASX leader and it looks like one of Australia’s top shares.

Read more »

Two smiling colleagues looking at a tablet in a data centre.
Growth Shares

Will Goodman shares reach $30 in 2027?

I look at the earnings forecasts to see how realistic a move back to this level could be.

Read more »